SMD Rise PCLBKK:SMD100-R 59 Equity-to-Asset is 0.49 as of Mar. 2026, which is 25% below its 10-year median of 0.65. GuruFocus rates BKK:SMD100-R with a GF Score™ of 59/100 and a GF Value™ of ฿22.94. The stock has 6 warning signs investors should review. Among 118 Medical Distribution companies, SMD Rise PCL ranks better than 65.25% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. SMD Rise PCL's Total Stockholders Equity for the quarter that ended in Mar. 2026 was ฿685.4 Mil. SMD Rise PCL's Total Assets for the quarter that ended in Mar. 2026 was ฿1,388.2 Mil.
Therefore, SMD Rise PCL's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.49.
The historical rank and industry rank for SMD Rise PCL's Equity-to-Asset or its related term are showing as below:
BKK:SMD100-R'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.34 Med: 0.65 Max: 0.87
Current: 0.49
During the past 8 years, the highest Equity to Asset Ratio of SMD Rise PCL was 0.87. The lowest was 0.34. And the median was 0.65.
BKK:SMD100-R's Equity-to-Asset is ranked better than 65.25% of 118
companies
in the Medical Distribution industry
Industry Median: 0.39
vs BKK:SMD100-R: 0.49
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
SMD Rise PCL Equity-to-Asset Related Terms
SMD Rise PCL Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for SMD Rise PCL's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SMD100-R vs MCK, CAH, COR: Equity-to-Asset Comparison
For the Medical Distribution subindustry, SMD Rise PCL's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SMD Rise PCL Equity-to-Asset vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where SMD Rise PCL's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
SMD Rise PCL's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SMD Rise PCL (BKK:SMD100-R) has a Equity-to-Asset of 0.49 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on SMD Rise PCL and its competitors. This is 25% below median its historical median of 0.65. Over the past decade, SMD Rise PCL's Equity-to-Asset has ranged from 0.34 to 0.87. According to the industry distribution chart, SMD Rise PCL ranks #41 out of 118 companies in the Medical Distribution industry, placing it in the top 34.7%.
Is SMD Rise PCL's Equity-to-Asset too high?
SMD Rise PCL's current Equity-to-Asset of 0.49 is 25% below median its 10-year median of 0.65. Over the past 10 years, this metric has ranged from a low of 0.34 to a high of 0.87. The Medical Distribution industry median Equity-to-Asset is 0.39. SMD Rise PCL's value of 0.49 is 25.6% above this industry median. Based on the distribution chart, SMD Rise PCL ranks #41 out of 118 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, SMD Rise PCL has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's Equity-to-Asset compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, SMD Rise PCL ranks #41 out of 118 companies for Equity-to-Asset. This puts SMD Rise PCL in the upper half of its industry. The industry median Equity-to-Asset is 0.39. SMD Rise PCL's value of 0.49 is 25.6% above this benchmark. Historically, SMD Rise PCL's own Equity-to-Asset has ranged from 0.34 to 0.87 over the past decade. While the company's 10-year median is 0.65 vs. the industry median of 0.39, SMD Rise PCL has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Distribution company?
The median Equity-to-Asset among Medical Distribution companies is 0.39, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SMD Rise PCL's current Equity-to-Asset of 0.49 is 25.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on SMD Rise PCL and its competitors. For the Medical Distribution industry, the median Equity-to-Asset is 0.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SMD Rise PCL's current Equity-to-Asset is 0.49, which is 25% below median its own 10-year median of 0.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current Equity-to-Asset of 0.49. The stock's GF Value™ is ฿22.94, compared to a current price of ฿5.85 — trading 74.5% below its estimated fair value. The current Equity-to-Asset is 0.49, which is 25% below median its 10-year median of 0.65 and 25.6% above the Medical Distribution industry median of 0.39. SMD Rise PCL's overall GF Score™ is 59/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current Equity-to-Asset is 0.49 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?
Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued.
The current stock price of ฿5.85 is trading 74.5% below its estimated GF Value™ of ฿22.94.
Key valuation signals for BKK:SMD100-R:
Equity-to-Asset: 0.49 (25% below median its 10-year median of 0.65)
GF Value™: ฿22.94 vs. price of ฿5.85 (74.5% below fair value)
Industry Position: 25.6% above the Medical Distribution median (#41 of 118)
No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Address222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
59GF Score
Get the complete analysis for BKK:SMD100-R
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SMD100-R has been successfully added to your 
